Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Atypical antipsychotic therapy in Parkinson's disease psychosis: A retrospective study.

Yuan M, Sperry L, Malhado-Chang N, Duffy A, Wheelock V, Farias S, O'Connor K, Olichney J, Shahlaie K, Zhang L.

Brain Behav. 2017 Apr 14;7(6):e00639. doi: 10.1002/brb3.639. eCollection 2017 Jun.

2.

A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

McGarry A, McDermott M, Kieburtz K, de Blieck EA, Beal F, Marder K, Ross C, Shoulson I, Gilbert P, Mallonee WM, Guttman M, Wojcieszek J, Kumar R, LeDoux MS, Jenkins M, Rosas HD, Nance M, Biglan K, Como P, Dubinsky RM, Shannon KM, O'Suilleabhain P, Chou K, Walker F, Martin W, Wheelock VL, McCusker E, Jankovic J, Singer C, Sanchez-Ramos J, Scott B, Suchowersky O, Factor SA, Higgins DS Jr, Molho E, Revilla F, Caviness JN, Friedman JH, Perlmutter JS, Feigin A, Anderson K, Rodriguez R, McFarland NR, Margolis RL, Farbman ES, Raymond LA, Suski V, Kostyk S, Colcher A, Seeberger L, Epping E, Esmail S, Diaz N, Fung WL, Diamond A, Frank S, Hanna P, Hermanowicz N, Dure LS, Cudkowicz M; Huntington Study Group 2CARE Investigators and Coordinators.

Neurology. 2017 Jan 10;88(2):152-159. doi: 10.1212/WNL.0000000000003478. Epub 2016 Dec 2.

3.

Allele-Specific Reduction of the Mutant Huntingtin Allele Using Transcription Activator-Like Effectors in Human Huntington's Disease Fibroblasts.

Fink KD, Deng P, Gutierrez J, Anderson JS, Torrest A, Komarla A, Kalomoiris S, Cary W, Anderson JD, Gruenloh W, Duffy A, Tempkin T, Annett G, Wheelock V, Segal DJ, Nolta JA.

Cell Transplant. 2016;25(4):677-86. doi: 10.3727/096368916X690863. Epub 2016 Feb 4.

4.

Human Mesenchymal Stem Cells Genetically Engineered to Overexpress Brain-derived Neurotrophic Factor Improve Outcomes in Huntington's Disease Mouse Models.

Pollock K, Dahlenburg H, Nelson H, Fink KD, Cary W, Hendrix K, Annett G, Torrest A, Deng P, Gutierrez J, Nacey C, Pepper K, Kalomoiris S, D Anderson J, McGee J, Gruenloh W, Fury B, Bauer G, Duffy A, Tempkin T, Wheelock V, Nolta JA.

Mol Ther. 2016 May;24(5):965-77. doi: 10.1038/mt.2016.12. Epub 2016 Jan 14.

5.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
6.

Developing stem cell therapies for juvenile and adult-onset Huntington's disease.

Fink KD, Deng P, Torrest A, Stewart H, Pollock K, Gruenloh W, Annett G, Tempkin T, Wheelock V, Nolta JA.

Regen Med. 2015;10(5):623-46. doi: 10.2217/rme.15.25. Review.

7.

Subjective Cognitive Complaints in Parkinson Disease Without Dementia: A Preliminary Study.

Koster DP, Higginson CI, MacDougall EE, Wheelock VL, Sigvardt KA.

Appl Neuropsychol Adult. 2015;22(4):287-92. doi: 10.1080/23279095.2014.925902. Epub 2014 Dec 12.

PMID:
25495957
8.

A case of familial ALS due to multi-system proteinopathy 1 and Huntington disease.

Oskarsson B, Wheelock V, Benatar M, Taylor JP, Joyce N, Chesak D, Jin LW.

Amyotroph Lateral Scler Frontotemporal Degener. 2015 Mar;16(1-2):124-6. doi: 10.3109/21678421.2014.952238. Epub 2014 Sep 10. No abstract available.

9.

Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis.

Goldenholz DM, Mehra N, Dahlin B, Cohen SH, Wheelock VL.

Neurology. 2013 Feb 19;80(8):e82. doi: 10.1212/WNL.0b013e3182825041. No abstract available.

PMID:
23420900
10.

Treatment of γ-aminobutyric acid B receptor-antibody autoimmune encephalitis with oral corticosteroids.

Goldenholz DM, Wong VS, Bateman LM, Apperson M, Oskarsson B, Akhtar S, Wheelock V.

Arch Neurol. 2012 Aug;69(8):1061-3. doi: 10.1001/archneurol.2012.197.

PMID:
22507884
11.

Genetically engineered mesenchymal stem cells as a proposed therapeutic for Huntington's disease.

Olson SD, Pollock K, Kambal A, Cary W, Mitchell GM, Tempkin J, Stewart H, McGee J, Bauer G, Kim HS, Tempkin T, Wheelock V, Annett G, Dunbar G, Nolta JA.

Mol Neurobiol. 2012 Feb;45(1):87-98. doi: 10.1007/s12035-011-8219-8. Epub 2011 Dec 9. Review.

12.

Predictors of HVOT performance in Parkinson's disease.

Higginson CI, Wheelock VL, Levine D, Pappas CT, Sigvardt KA.

Appl Neuropsychol. 2011 Jul;18(3):210-5. doi: 10.1080/09084282.2011.595447.

13.

Cerebral venous sinus thrombosis presenting with auditory hallucinations and illusions.

Wong VS, Adamczyk P, Dahlin B, Richman DP, Wheelock V.

Cogn Behav Neurol. 2011 Mar;24(1):40-2. doi: 10.1097/WNN.0b013e318217b0cd.

PMID:
21467920
14.

The clinical significance of neuropsychological changes following bilateral subthalamic nucleus deep brain stimulation for Parkinson's disease.

Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA.

J Clin Exp Neuropsychol. 2009 Jan;31(1):65-72. doi: 10.1080/13803390801982734. Epub 2008 May 19.

PMID:
18608676
15.

Cognitive deficits in essential tremor consistent with frontosubcortical dysfunction.

Higginson CI, Wheelock VL, Levine D, King DS, Pappas CT, Sigvardt KA.

J Clin Exp Neuropsychol. 2008 Oct;30(7):760-5. doi: 10.1080/13803390701754738. Epub 2008 Feb 15.

PMID:
18608666
16.

Dopamine dependency of cognitive switching and response repetition effects in Parkinson's patients.

Shook SK, Franz EA, Higginson CI, Wheelock VL, Sigvardt KA.

Neuropsychologia. 2005;43(14):1990-9.

PMID:
16243049
17.

Recognition memory in Parkinson's disease with and without dementia: evidence inconsistent with the retrieval deficit hypothesis.

Higginson CI, Wheelock VL, Carroll KE, Sigvardt KA.

J Clin Exp Neuropsychol. 2005 May;27(4):516-28.

PMID:
15962695
18.

Temporal evolution of oscillations and synchrony in GPi/muscle pairs in Parkinson's disease.

Hurtado JM, Rubchinsky LL, Sigvardt KA, Wheelock VL, Pappas CT.

J Neurophysiol. 2005 Mar;93(3):1569-84. Epub 2004 Oct 20.

19.

The relationship between executive function and verbal memory in Parkinson's disease.

Higginson CI, King DS, Levine D, Wheelock VL, Khamphay NO, Sigvardt KA.

Brain Cogn. 2003 Aug;52(3):343-52.

PMID:
12907179
20.

Predictors of nursing home placement in Huntington disease.

Wheelock VL, Tempkin T, Marder K, Nance M, Myers RH, Zhao H, Kayson E, Orme C, Shoulson I; Huntington Study Group.

Neurology. 2003 Mar 25;60(6):998-1001.

PMID:
12654967
21.

FMD control strategies.

Haywood S, Binns S, Crispin S, Roger P, Wheelock V.

Vet Rec. 2001 Oct 27;149(17):530-1. No abstract available.

PMID:
11708642
23.

Utilization of unilateral and bilateral stereotactically placed adrenomedullary-striatal autografts in parkinsonian humans: rationale, techniques, and observations.

Apuzzo ML, Neal JH, Waters CH, Appley AJ, Boyd SD, Couldwell WT, Wheelock VH, Weiner LP.

Neurosurgery. 1990 May;26(5):746-57.

PMID:
2191238
24.

Public perception of food safety.

Wheelock V.

J R Soc Health. 1988 Aug;108(4):130-1. No abstract available.

PMID:
3142999
25.

Conference paper: the food revolution.

Wheelock V.

Midwife Health Visit Community Nurse. 1988 Mar;24(3):78-9. No abstract available.

PMID:
3380030
26.

Care about food. Healthy choices.

Wheelock V.

Nurs Times. 1985 Mar 20-26;81(12):43-4. No abstract available.

PMID:
3845498

Supplemental Content

Loading ...
Support Center